FSHD2 is a rare form of facioscapulohumeral muscular dystrophy (FSHD) characterized by the absence of a contraction in the D4Z4 macrosatellite repeat region on chromosome 4q35 that is the hallmark of FSHD1. However, hypomethylation of this region is common to both subtypes. Recently, mutations in SMCHD1 combined with a permissive 4q35 allele were reported to cause FSHD2. We identified a novel p.Lys275del SMCHD1 mutation in a family affected with FSHD2 using whole-exome sequencing and linkage analysis. This mutation alters a highly conserved amino acid in the ATPase domain of SMCHD1. Subject III-11 is a male who developed asymmetrical muscle weakness characteristic of FSHD at 13 years. Physical examination revealed marked bilateral atrophy at biceps brachii, bilateral scapular winging, some asymmetrical weakness at tibialis anterior and peroneal muscles, and mild lower facial weakness. Biopsy of biceps brachii in subject II-5, the father of III-11, demonstrated lobulated fibers and dystrophic changes. Endomysial and perivascular inflammation was found, which has been reported in FSHD1 but not FSHD2. Given the previous report of SMCHD1 mutations in FSHD2 and the clinical presentations consistent with the FSHD phenotype, we conclude that the SMCHD1 mutation is the likely cause of the disease in this family.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Neuromuscular Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Clinical features of facioscapulohumeral muscular dystrophy 2.Neurology. 2010; 75: 1548-1554
- A unifying genetic model for facioscapulohumeral muscular dystrophy.Science. 2010; 329: 1650-1653
- SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation.Nat Genet. 2008; 40: 663-669
- Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2.Nat Genet. 2012; 44: 1370-1374
- Efficient identification of novel mutations in patients with limb girdle muscular dystrophy.Neurogenetics. 2010; 11: 449-455
- Fast and accurate short read alignment with Burrows–Wheeler transform.Bioinformatics. 2009; 25: 1754-1760
- A framework for variation discovery and genotyping using next-generation DNA sequencing data.Nat Genet. 2011; 43: 491-498
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.Nucleic Acids Res. 2010; 38: e164
- BISMA – fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences.BMC Bioinformatics. 2010; 11: 230
- Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.Hum Mol Genet. 2012; 21: 4419-4430
- DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.Proc Natl Acad Sci USA. 2007; 104: 18157-18162
- Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.PLoS Genet. 2010; 6: e1001181
- At the heart of the chromosome: SMC proteins in action.Nat Rev Mol Cell Biol. 2006; 7: 311-322
- Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.Muscle Nerve. 1995; 2: S56-S66
Published online: October 14, 2013
Accepted: August 19, 2013
Received in revised form: July 24, 2013
Received: April 29, 2013
© 2013 Elsevier B.V. Published by Elsevier Inc. All rights reserved.